Evidence map›Paper›PMID 42741744›Full record

ArticleSmall science2026

Integration of NanoMIPs With Gold-Patterned Plasmonic Surfaces as Synthetic Protein A.

Fabiana Grillo, Francesco Gentile, Francesco Canfarotta, Maria Laura Coluccio, Elena Piletska, Donald Jones, Thong H Cao, Virginia Garo, Nilde Fera, Sandro Dragone and 3 more

Abstract read
In one paragraph

Article in Small science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Fabiana GrilloDepartment of Chemistry University of Leicester Leicester UK.ORCID https://orcid.org/0000-0002-8095-6816
Francesco GentileDepartment of Experimental and Clinical Medicine, BioNEM Lab University Magna Graecia Catanzaro Italy.
Francesco CanfarottaTozaro Ltd. Sharnbrook UK.ORCID https://orcid.org/0000-0001-9837-100X
Maria Laura ColuccioDepartment of Experimental and Clinical Medicine, BioNEM Lab University Magna Graecia Catanzaro Italy.
Elena PiletskaSchool of Chemistry, College of Science and Engineering University of Leicester Leicester UK.ORCID https://orcid.org/0000-0003-0122-1764
Donald JonesDepartment of Cancer Studies, RKCSB University of Leicester Leicester UK.ORCID https://orcid.org/0000-0001-6583-870X
Thong H CaoDepartment of Cardiovascular Sciences University of Leicester Leicester UK.ORCID https://orcid.org/0000-0002-6559-0836
Virginia GaroDepartment of Health Sciences University Magna Graecia Catanzaro Italy.
Nilde FeraDepartment of Medical and Surgical Sciences University Magna Graecia Catanzaro Italy.ORCID https://orcid.org/0009-0002-2073-1356
Sandro DragoneDepartment of Medical and Surgical Sciences University Magna Graecia Catanzaro Italy.ORCID https://orcid.org/0009-0009-1535-1333
Patrizio CaldeloroDepartment of Experimental and Clinical Medicine, BioNEM Lab University Magna Graecia Catanzaro Italy.ORCID https://orcid.org/0000-0001-6156-887X
Sergey PiletskySchool of Chemistry, College of Science and Engineering University of Leicester Leicester UK.ORCID https://orcid.org/0000-0003-2052-5763
Natalia MalaraDepartment of Experimental and Clinical Medicine, BioNEM Lab University Magna Graecia Catanzaro Italy.ORCID https://orcid.org/0000-0002-1719-293X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In modern bioanalytical sensing, the integration of biorecognition elements with transducer platforms represents an established strategy for achieving selective detection. Among the available bioreceptors, proteins have been widely used for their ability to mediate highly specific interactions. However, proteins often present limitations such as instability, high production costs, animal-derived manufacturing, and strict storage protocols. A promising alternative is molecularly imprinted polymeric nanoparticles (nanoMIPs), which have shown potential due to features such as greater stability, durability, and potentially lower costs. This study introduces, for the first time, the use of nanoMIPs imprinted for IgG on a silicon surface functionalised with gold nanoparticles. These nanoMIPs are designed to bind IgG in an oriented manner by targeting Fc-specific epitopes selected through a novel epitope-mapping technique. Detection is based on metal-enhanced fluorescence (MEF), which significantly amplifies the signal. The sensor showed high specificity for IgG, with no cross-reactivity toward IgA, reaching a detection limit of 10 ng mL

Indexed as

gold nanoparticlesIgGmetal‐enhanced fluorescencenanoMIPsprotein

Identifiers

PMID42741744
PMCPMC13574059

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.